STAT5 has been shown to interact with the androgen receptor, via its DNA binding domain, and protect it against proteosomal degradation, which can induce tumor growth in prostate cancer cells and may not require Jak [163]. The gene discussed is STAT5A; the disease is Familial prostate cancer.